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Assayable derivatives of ascorbate  in mammalian tissues include reduced 
ascorbate (AA), 1 dehydroascorbate (DHA), and diketogulonate (DKG). Only 
AA and DHA are antiscorbutic. 
After intravenous administration to  mammals,  DHA is retained longer in 
whole blood than is AA; other tissues accumulate AA more avidly than DHA 
(1-3). With the exception of the findings in one study (4), it appears that DHA 
is taken up more rapidly than AA by human and guinea pig erythrocytes and 
leukocytes in vitro (5-7). It has been suggested that DHA, which is more lipid 
soluble than AA, is the form of ascorbate which penetrates cell membranes (8). 
When DHA or AA  are  injected into mammals,  both  are  concentrated in 
tissues as AA (2, 3, 8, 9). Most mammalian tissues incubated in vitro with AA 
or DHA  also  accumulate AA  (6,  10,  11);  however,  guinea pig  erythrocytes 
incubated with DHA accumulate predominantly DHA (5). 
Three DHA-reducing activities are described in mammalian tissues: reduced 
glutathione-dependent activity in erythrocytes and liver of several species  (12), 
NADPH-dependent activity in the granule fraction of human leukocytes (13) 
and  NADH-dependent  activity  (reduced  NAD(P):  semidehydroascorbate 
oxidoreductase, EC 1.6.5.4.)  in microsomes of several pig and rat tissues (14, 
15). Reduction of DHA by each of these activities could directly or indirectly 
lead  to  oxidation  of  NADPH,  and  result  in  hexose  monophosphate  shunt 
(HMS) activation. This report describes studies of AA and DHA uptake, DHA 
reduction, and coincident HMS stimulation in human leukocytes. 
Materials and Methods 
Materials.--L-ascorbic  acid, sodium salt, was obtained from Sigma Chemical Co., St. Louis, 
Mo. DHA was prepared from L-ascorbic acid by the technique of Pecherer (16)  and purified 
by the method of Staudinger and Weis  (17).  These preparations of AA and DHA contained 
no contaminants detectable by thin-layer chromatography (5)  or by the assay of Roe et al. 
*This work was supported by NIH grant AM 13173 from the National Institute of Arthritis 
and Metabolic Disease. 
1  Abbreviations used in this paper: AA, reduced ascorbate; DHA, dehydroascorbate; DKG, 
diketogulonate; HMS,  hexose monophosphate shunt; WBC, leukocytes. 
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(18), which quantitatively distinguishes AA, DHA, and DKG from each other, and from other 
organic compounds. 
Leukocyte Separation.--All  steps were performed at 25-28°C, using nonwettable containers. 
To each  10 ml of human  venous blood, drawn into a  plastic syringe containing 0.1  ml of 
heparin (beef lung, 1,000 U/ml; Upjohn Co., Kalamazoo, Mich.), 2 ml of 6% Dextran  (tool 
wt  117,000;  Sigma Chemical Co.) in phosphate-buffered  saline, pH 7.4,  were added.  After 
sedimentation for 60-90 min, superuatant  plasma was separated and  diluted with 2 vol of 
0.87% ammonium chloride to lyse the remaining erythrocytes, then centrifuged at 250 g for 
5 min. Sedimented leukocytes were washed twice with calcium free Krebs-Ringer phosphate 
buffer, pH 7.4, containing glucose,  1 mg/ml, and resuspended in approximately 10 vol of the 
same medium. Calcium-free media were used here and in subsequent experiments to avoid 
phagocyte clumping. Cells were counted in a hemacytometer chamber. Leukocyte differential 
counts, determined from Wright's-stained smears, varied within 85-95%  neutrophil granu- 
locytes, 5-15% monocytes, 0-8% lymphocytes, and 0-5% eosinophil granulocytes. 
Measurement of Ascorbate Uptake.--Leukoeytes  were incubated  at  37°C in calcium-free 
Krebs-Ringer phosphate buffer containing 5.5 mM glucose (1 mg/ml) and either DHA or AA, 
for periods of time that are noted in the Results. Reaction mixtures were gassed with 95% 
02 and 5% CO2 for aerobic experiments, and with 95% Ns and 5% COs for anaerobic experi- 
ments. Gas flow rate was 73 ml/min. Gases contained 5% COs in order to assure that condi- 
tions for measuring ascorbate uptake and HMS activity were comparable. Leukocytes (WBC) 
tend to clump in Krebs-Ringer bicarbonate buffer, the standard medium for COs-incubated 
experiments,  therefore Krebs-Ringer phosphate  buffer  was  substituted.  Using this  buffer, 
reaction mixture pH was 7.10 after gassing with 5% COs for 20 min, 7.05 after 30 min, and 
6.95 after 60 rain. Control experiments showed no effect of CO2 gassing on DHA uptake and 
reduction, or on HMS activity measured by scintillation counting. 
Paired flasks  containing cells and medium were prdncubated and gassed for 20 rain. One 
flask of eachpair was then removed for "zero time" control assay and, simultaneously, a freshly 
prepared  solution of AA or DHA in pregassed Krebs-Ringed phosphate,  final pH  7.1,  was 
added  to the remaining flask  through  a  capillary tube.  Ascorbate uptake  was  stopped  by 
placing reaction tubes in an ice water bath. Cells were separated from medium by centrifuga- 
tion at 250 g for 5 min at 4°C and washed twice with Krebs-Ringer phosphate buffer. AA and 
DHA contents of cells and medium were then measured by the method of Roe et al.  (18). 
Using this method, DHA lost from medium is recovered as AA increase in cells with 98.5  4- 
1.1% accuracy. DKG was not detectable when 20-40 X  10 s cells were analyzed, either before 
or after incubation with AA or DHA. 
Measurement of HMS Activ/ty.--The rate of 14CO2 production from 14C-1 glucose (New 
England Nuclear, Boston, Mass.)  was measured continuously, using the gas flow-ionization 
chamber method of Davidson and Tanaka (19). This technique converts charge accumulated 
in an ionization chamber to a millivolt signal by the high resistance leak method, using a Cary 
model 401 vibrating reed electrometer (Cary Instruments, Monrovia, Calif.). The signal was 
recorded continuously on a Sargent SRG recorder (Sargent Welch Co., Skokie, Ill.). A signal 
of 1.0 mV read at 10 rain is equivalent to 44.8 X  10  -5 #Ci t4C-1 glucose oxidized in 10 min, 
determined  by parallel measurements  of  14CO2 evolution by liquid scintillation counting. 
Using this method, resting WBC oxidize 5.9-7.8 nmol of C-1  glucose/10  s cells/10 min, and 
phagocytosing WBC oxidize 35.0-39.3  umol/10  s cells/10 min. These values are comparable 
to those reported using scintillation counting methods (13, 20). 
1-ml reaction mixtures containing 20-40 X  10 s WBC and 2.8 mM (0.5 mg/ml) of glucose 
which included 1.0 #Ci of 14C-1 glucose were incubated in 20-ml flat-bottomed glass vials in a 
Dubnoff shaking incubator (Precision Scientific Co., Chicago, Ill.)  at 37°C,  80 oscillations/ 
min. Gases and flow rates were as stated above. Depth of the reaction mixture was 2 mm and 
the surface area was 5 cm  2. CO2 diffusion from the medium was inefficient when larger reac- 1086  ASCORBATE  UPTAKE  AND  REDUCTION 
tion volumes with smaller surface area to volume ratios were used. Gas was not bubbled 
through the reaction mixture, since this caused clumping of and damage to WBC. 
RESULTS 
Cells Incubated with DHA.--Human WBC extract DHA efficiently from the 
surrounding  medium,  and  promptly  reduce  it  to AA.  The  amount  of DHA 
taken up and reduced is proportional to the number of cells and to the concen- 
tration of ])HA in the medium  (Fig.  1). The figure does not reflect the DHA 
content of unincubated  cells,  which ranged from 0.012-0.028 ~mol/10  s WBC 
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FIG. 1. Uptake and reduction of DHA by leukocytes. (a) Effect of numbers of WBC. 5-ml 
reaction  mixtures  containing DHA, 100 #g/ml, were incubated  for 20 rain. AA and DHA 
contents of unincubated cells were subtracted  from observed values to obtain AA increase in 
ceils. (b) Effect of medium DHA concentration.  In a total volume of 10 ml, 40 X  106 WBC 
were incubated with DHA for 20 min. Cell AA increase was calculated as in Fig. 1 a. 
and was unchanged after incubation of cells with DHA. The increase in cellular 
AA after incubation was equal to DHA loss from medium. The rate of DHA 
uptake and reduction by cells is dependent on the DHA concentration in  the 
medium, is biphasic,  and is  the  same under  aerobic and  anaerobic conditions 
(Fig. 2). 
As cells take up and reduce DHA, glucose oxidation through the HMS is in- 
creased (Fig. 3). The enhancement of HMS activity induced by incubation with 
DHA is the same under aerobic and anaerobic conditions, and is dependent on 
DHA concentration in the medium. The difference in absolute values between 
samples  incubated  aerobically  and  anaerobically  reflects  oxygen-dependent 
HMS activity, independent of stimulation by DHA. ROBERT  H. BIGLEY  AND  LIBUSE  STANKOVA  1087 
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FIG. 2. Rate of DHA uptake and reduction by WBC; effects of medium DHA concentra- 
tion and of oxygenation. In a  total vol of 5 ml, 20 X  l0 s WBC were incubated with DHA. 
Incubation vials were gassed with 95% O3 and 5%  COs, except for the samples labeled 
Anaerobic which were gassed with 95% N2 and 5% COs • AA and DHA contents of nnincu- 
bated cells were subtracted from observed values to obtain AA increase in cells. 
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Fla. 3. Effect of DHA medium concentration on HMS activity.  In a total vol of 0.9 ml, 
30 X 106 WBC were incubated with 1.5 #Ci of t4C-1 glucose. C-1 glucose oxidation was calcu- 
lated as described in Materials and Methods. 
Cells enriched 20-fold with AA by previous incubation with DHA followed 
by washing had the same HMS activity as did control cells. HMS stimulation 
is thus related to ])HA uptake and reduction, and is not related to AA content 
of cells. 
Cells Incubated with AA.--When AA is used instead of DNA,  remarkable 
differences are observed. AA added to the medium causes WBC AA content 
and HMS  activity to increase only when the reaction mixture is oxygenated 1088  ASCORBATE UPTAKE AND REDUCTION 
(Table I).  Much  higher medium concentrations of AA than  of DHA  are re- 
quired in order to produce comparable increases in cell AA content and HMS 
activity; with medium AA concentrations less than  100 t~g/ml, no increase in 
cell AA content  or  HMS  activity  was  detectable.  The increase in WBC  AA 
content and HMS activity observed during incubation with a given concentra- 
tion of AA in the medium varied considerably among experiments using WBC 
from different donors; no  such variation between donors was  seen when cells 
were incubated with DHA. 
The ratio of HMS increase to increase in cell AA content is the same when 
either AA or DHA is added to the medium (Table II).  This quantitative rela- 
tionship  implies  that NADPH  oxidation is in  some way involved in  uptake 
and/or reduction of one or both ascorbate derivatives. 
TABLE I 
Effects of A naerobic and Aerobic Incubation with AA  on WBC AA  Content and HMS Activity* 
Cell AA*  HMS activity§ 
Control  AA  Control  AA 
Anaerobic¶  124.0  126.0  1.05  1.05 
Aerobic¶  124.0  192.0  7.53  15.48 
* Cell AA was measured after washing 90 X  106 WBC that were incubated  for 10 min in 
3-ml reaction mixtures without or with 3 mg AA. HMS activity was measured  10 rain after 
adding 0.1 ml of buffer without or with 1 mg AA through  a capillary  to 0.9 ml of reaction 
mixture containing 30 X  106 WBC and 1.5 #Ci 14C-1 glucose. 
:~ umol/lO  8 WBC. 
§ nmol glucose oxidized/108 WBC. 
¶ Aerobic incubations  were gassed with 95% 02 and 5% CO2 ; anerobic incubations  were 
gassed with 95% N2 and 5% CO2. 
TABLE II 
Effects of Aerobic Incubation with DHA  or AA  on  WBC AA  Content  and  ItMS  Activity* 
Cell AAincrease*  HMS increase§  HMS increase/cell  AAincrease¶ 
Medium ascorbate 
DHA 20 tzg/ml  100.0  12.00  0.12 
DHA 40/~g/ml  200.0  24.05  0.12 
AA 1000 #g/ml  68.0  7.94  0.12 
* Conditions are described under Table I. Values for unincubated HMS activity and cell AA 
and DHA were subtracted  from final values to obtain the increase in each measurement. 
nmol AA/10  s WBC. 
§ nmol glucose oxidized/10 s WBC. 
¶ nmol glucose oxidized/nmol  AA. ROBERT  H.  BIGLEY  AND  LIBUSE  STANKOVA  1089 
DISCUSSION 
These studies show that human WBC take up extracellular DHA and reduce 
it promptly to AA. The process of converting extracellular DHA to intracellular 
AA is accompanied by HMS activation. DHA uptake and reduction and HMS 
activation are dependent on DHA concentration in medium, and do not require 
oxygen. As cells take up and reduce 1.0 #mol of DNA, they oxidize 0.i2 ~mol 
of C-1 glucose, and therefore utilize only 0.24 ~mol of NADPH. NADPH thus 
appears to contribute protons for DHA reduction either indirectly, or directly 
along with one or more other donors. 
Human WBC do not take up AA from the medium in the absence of oxygen, 
but they do accumulate AA when oxygen is supplied. These observations are 
consistent with separate mechanisms for uptake of DHA and AA in leukocytes, 
that for DHA being anaerobic and that for AA being aerobic; alternatively, 
AA may require oxidation to DHA in the medium before uptake. It has been 
suggested that ascorbate-induced HMS stimulation in the human lens (21) and 
in human WBC  (22)  is a  consequence of the metabolism of DHA produced 
during oxidation of AA.  We observe that  the ratio of HMS  stimulation  to 
WBC  AA increase is  the same,  regardless whether cells are incubated with 
DHA or aerobically with AA. This suggests that shunt stimulation is a quantita- 
tive though not stoichiometric reflection of intracellular DHA reduction in both 
instances, and that in both instances DHA is the derivative of ascorbate taken 
up from the medium by WBC. 
AA can be converted to DHA by cation-catalysed auto-oxidation, and by 
H~O2-dependent,  peroxidase-catalysed oxidation  (23).  We  observe that  cells 
from different donors accumulate AA at different rates from media containing 
AA. This variation could result from variation in medium cation content con- 
tributed by cells or glassware. It could also result from variation in release of 
myeloperoxidase from damaged WBC into the medium which contains H202 
produced by the WBC. The latter possibility is unlikely, since Cooper et al. 
(22)  have shown that WBC HMS stimulation by AA is independent of WBC 
capacity to produce H2(h. It is also possible that some of the variation may 
reflect cellular control of AA uptake.  Mechanisms for control of cellular as- 
corbate levels have not been described. Possibly, regulation of the AA content 
of WBC is mediated in part through control of AA oxidation to DHA in the 
extracellular fluid or at the cell membrane. 
In erythrocytes incubated aerobically with AA,  HMS stimulation may be 
caused  by glutathione  peroxidase-catalysed oxidation of the  H202  produced 
during auto-oxidation of AA (23, 24). It is not likely that this mechanism con- 
tributes to HMS stimulation in our studies of WBC incubated with AA.  If 
H20, derived from AA oxidation had added to shunt activity, the HMS increase 
to cell AA increase ratio  should have been higher when  cells were incubated 
with AA than when they were incubated with DHA, since H~O2 is not produced 1090  ASCORBATE UPTAKE AND REDUCTION 
during DHA oxidation. It may be that WBC catalase reduces the H202 which 
diffuses  into  cells,  and/or  that  the  H~O2 produced  in  the  medium  oxidizes 
another molecule of AA to DHA, as proposed by de Chalelet et al. (25). 
Membrane lipids of phagocytosed bacteria are peroxidated (26). Since diffus- 
ble  H202  and  activated oxygen are produced by active phagocytes  (27-29), 
membrane lipids and other constituents of the phagocytosing cell might also 
suffer  critical  oxidative  denaturation  unless  the  cell  is  able  to  repair  such 
damage.  Green  and  O'Brien  (30)  demonstrated  that  ascorbate  enhances 
NADH-dependent reduction of a lipid peroxide. They found this activity in rat 
liver mitochondria and microsomes, and proposed that semidehydroascorbate 
reductase  participates  in  the  reaction.  During  10  minutes  of phagocytosis, 
l0  s WBC consume 1,000/zmol of oxygen (31). In the same time, as shown in 
Fig. 1, l0  s WBC can reduce more than 2,000 #mol of DHA to AA. Thus, human 
WBC have considerable capacity to regenerate AA promptly after oxidation. 
This DHA-reducing system may function along with AA as a significant part 
of the cell's mechanism for prevention of oxidative damage to cell constituents. 
SUMMARY 
Incubation of human leukocytes w~th dehydroascorbate (DHA) results in an 
increase in their reduced ascorbate  (AA)  content and hexose monophosphate 
shunt  (HMS)  activity, independent  of oxygen supply.  Incubation with  AA 
induces these changes only in the presence of oxygen. The increase in HMS 
activity observed as cell AA increases by 1 ~tmol is the same during incubation 
with either DHA or AA. 
We propose that  human leukocytes take up  ascorbate as DHA  (AA after 
oxidation to DHA) and reduce it promptly to AA, and that HMS stimulation 
upon incubation with either AA or DHA is a result of DHA reduction. 
We are grateful to Dr. Evelyn Oginsky for her critical review of the manuscript. 
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